NO974062L - Fremgangsmåte og kitt for å hindre erektil funksjonssvikt - Google Patents

Fremgangsmåte og kitt for å hindre erektil funksjonssvikt

Info

Publication number
NO974062L
NO974062L NO974062A NO974062A NO974062L NO 974062 L NO974062 L NO 974062L NO 974062 A NO974062 A NO 974062A NO 974062 A NO974062 A NO 974062A NO 974062 L NO974062 L NO 974062L
Authority
NO
Norway
Prior art keywords
erectile dysfunction
putty
procedures
preventing
prevent erectile
Prior art date
Application number
NO974062A
Other languages
English (en)
Other versions
NO974062D0 (no
Inventor
Virgil A Place
Original Assignee
Vivus Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vivus Inc filed Critical Vivus Inc
Publication of NO974062D0 publication Critical patent/NO974062D0/no
Publication of NO974062L publication Critical patent/NO974062L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/41—Devices for promoting penis erection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/16—Male reproductive, genital organs
    • A61M2210/167—Penis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nursing (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Det beskrives en fremgangsmåte for å hindre erektil funksjonssvikt, fortrinnsvis vaskulogenisk impotens, i et hannkjønn-individ. Fremgangsmåten involverer periodisk administrering av et vasoaktivt middel i løpet av en 24- timers periode. Midlet og doseringsregimet velges slik at det oppnås en regelmessig økt blodstrøm til penis, noe som hindrer arteriell okklusjon og vaskulær forringelse av de muskulære fibre av kar og kollagenfibre av kavernøse vev.
NO974062A 1995-03-14 1997-09-04 Fremgangsmåte og kitt for å hindre erektil funksjonssvikt NO974062L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40333395A 1995-03-14 1995-03-14
PCT/US1996/003086 WO1996028142A1 (en) 1995-03-14 1996-03-07 Method and kit for preventing erectile dysfunction

Publications (2)

Publication Number Publication Date
NO974062D0 NO974062D0 (no) 1997-09-04
NO974062L true NO974062L (no) 1997-09-15

Family

ID=23595398

Family Applications (1)

Application Number Title Priority Date Filing Date
NO974062A NO974062L (no) 1995-03-14 1997-09-04 Fremgangsmåte og kitt for å hindre erektil funksjonssvikt

Country Status (17)

Country Link
US (1) US5820587A (no)
EP (1) EP0814775A1 (no)
JP (1) JPH10505611A (no)
KR (1) KR19980703052A (no)
AU (1) AU5358896A (no)
BR (1) BR9607365A (no)
CA (1) CA2215307A1 (no)
CZ (1) CZ278497A3 (no)
DE (1) DE814775T1 (no)
ES (1) ES2110380T1 (no)
HU (1) HUP9801324A3 (no)
NO (1) NO974062L (no)
NZ (1) NZ305560A (no)
PL (1) PL322268A1 (no)
SK (1) SK124397A3 (no)
TR (1) TR199700930T2 (no)
WO (1) WO1996028142A1 (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6143746A (en) * 1994-01-21 2000-11-07 Icos Corporation Tetracyclic cyclic GMP-specific phosphodiesterase inhibitors, process of preparation and use
GR1002847B (el) 1997-05-06 1998-01-27 Χρηση της μισοπροστολης ή/και της μισοπροστολης οξυ για την παρασκευη φαρμακευτικου προιοντος για τη θεραπευτικη αντιμετωπιση των δυσλειτουργιων της στυσεως
JP2001509480A (ja) 1997-07-09 2001-07-24 アンドロソリューションズ，インク． 男性勃起機能不全を治療するための改良された方法及び組成物
US6103765A (en) 1997-07-09 2000-08-15 Androsolutions, Inc. Methods for treating male erectile dysfunction
US5947901A (en) * 1997-09-09 1999-09-07 Redano; Richard T. Method for hemodynamic stimulation and monitoring
US6037360A (en) * 1997-10-28 2000-03-14 Vivus, Incorporated Administration of 5-HT3 receptor antagonists to treat premature ejaculation
US5922341A (en) * 1997-10-28 1999-07-13 Vivus, Incorporated Local administration of pharmacologically active agents to treat premature ejaculation
US6228864B1 (en) 1997-10-28 2001-05-08 Vivus, Inc. Administration of 5-HT receptor agonists and antagonists, to treat premature ejaculation
ES2155740B1 (es) * 1998-03-31 2001-12-01 Vita Invest Sa Dispositivo intrauretral para el tratamiento de la disfuncion erectil.
US6056966A (en) * 1998-05-18 2000-05-02 Baker Norton Pharmaceuticals, Inc. Method and compositions for treating impotence
GR1003199B (el) 1998-08-14 1999-09-01 Χρηση της μισοπροστολης ή και της μισοπροστολης οξυ για την παρασκευη φαρμακευτικου προιοντος για τη θεραπευτικη αντιμετωπιση της σεξουαλικης δυσλειτουργιας στις γυναικες
CA2340206A1 (en) 1998-08-26 2000-03-09 Queen's University At Kingston Use of anti-pressor agents for vascular remodeling in genital dysfunction
KR100350179B1 (ko) * 1998-09-23 2002-08-27 구주제약주식회사 Ｓｅｄｄｓ로 제제화한 발기부전치료용 주입액제
US6486207B2 (en) 1998-12-10 2002-11-26 Nexmed (Holdings), Inc. Compositions and methods for amelioration of human female sexual dysfunction
US6825234B2 (en) 1998-12-10 2004-11-30 Nexmed (Holdings) , Inc. Compositions and methods for amelioration of human female sexual dysfunction
FR2789586A1 (fr) * 1999-02-16 2000-08-18 Synthelabo Composition pharmaceutique pour administration transmucosale balanique d'alfuzosine
AU3713600A (en) * 1999-03-01 2000-09-21 Nitromed, Inc. Nitrosated and nitrosylated prostaglandins, compositions and metods of use
IT1312310B1 (it) 1999-05-07 2002-04-15 Recordati Ind Chimica E Farma Uso di antagonisti selettivi del recettore adrenergico a 1b per ilmiglioramento della disfunzione sessuale
US6693135B2 (en) 2000-01-10 2004-02-17 Nexmed (Holdings) Incorporated Prostaglandin compositions and methods of treatment for male erectile dysfunction
US6323241B1 (en) 2000-01-10 2001-11-27 Nexmed (Holdings) Inc. Prostaglandin compositions and methods of treatment for male erectile dysfunction
US7105571B2 (en) * 2000-01-10 2006-09-12 Nexmed Holdings, Inc. Prostaglandin compositions and methods of treatment for male erectile dysfunction
KR20010076961A (ko) * 2000-01-29 2001-08-17 김제종 성기능장애 예방 및 치료용 약제
GB0130704D0 (en) * 2001-12-21 2002-02-06 Glaxo Group Ltd New use
SI1750766T1 (sl) 2004-05-11 2013-11-29 Emotional Brain B.V. Farmacevtske formulacije in njihove uporabe pri zdravljenju spolne disfunkcije pri Ĺľenskah
EP1790343A1 (en) 2005-11-11 2007-05-30 Emotional Brain B.V. Pharmaceuticals formulations and uses thereof in the treatment of female sexual dysfunction
EP1925307A1 (en) 2006-11-03 2008-05-28 Emotional Brain B.V. Use of 3-alpha-androstanediol in the treatment of sexual dysfunction
US9005183B2 (en) * 2007-05-16 2015-04-14 Health Knight, Llc System and method for treating erectile dysfunction
US8986253B2 (en) 2008-01-25 2015-03-24 Tandem Diabetes Care, Inc. Two chamber pumps and related methods
US8408421B2 (en) 2008-09-16 2013-04-02 Tandem Diabetes Care, Inc. Flow regulating stopcocks and related methods
CA2737461A1 (en) 2008-09-19 2010-03-25 Tandem Diabetes Care, Inc. Solute concentration measurement device and related methods
EP3284494A1 (en) 2009-07-30 2018-02-21 Tandem Diabetes Care, Inc. Portable infusion pump system
US9180242B2 (en) 2012-05-17 2015-11-10 Tandem Diabetes Care, Inc. Methods and devices for multiple fluid transfer
US9173998B2 (en) 2013-03-14 2015-11-03 Tandem Diabetes Care, Inc. System and method for detecting occlusions in an infusion pump
BR102019016950A2 (pt) * 2019-08-15 2021-02-23 Inst De Pesquisa Ensino Ciencia E Tecnologia Aplicada Inst Galzu forma de dosagem intrauretral de medicamento; e dispositivo

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2097520A5 (no) * 1970-07-09 1972-03-03 Morel Paul
US3797493A (en) * 1970-11-20 1974-03-19 E Saudek Single use container, especially for pharmaceutical material
US4127118B1 (en) * 1977-03-16 1995-12-19 Alvaro Latorre Method of effecting and enhancing an erection
CA1135827A (en) * 1978-12-04 1982-11-16 Rainer Fehr Determination of flow velocities by measuring phase difference between the doppler signals
US4311707A (en) * 1979-02-12 1982-01-19 American Cyanamid Company Process for topically producing cutaneous vasodilation for the treatment of vasospastic or ischemic conditions
JPS5836528A (ja) * 1981-08-28 1983-03-03 株式会社東芝 超音波パルスドツプラ血流測定装置
US4612937A (en) * 1983-11-10 1986-09-23 Siemens Medical Laboratories, Inc. Ultrasound diagnostic apparatus
US4585005A (en) * 1984-04-06 1986-04-29 Regents Of University Of California Method and pacemaker for stimulating penile erection
US4828544A (en) * 1984-09-05 1989-05-09 Quotidian No. 100 Pty Limited Control of blood flow
US5219885A (en) * 1987-02-16 1993-06-15 Froelich Juergen Prostaglandin E1 derivatives as pharmaceutically active agents, and pharmaceutical compositions containing these compounds, especially for transcutaneous administration
US4801587A (en) * 1987-03-02 1989-01-31 Gene Voss Impotence ointment
SE463851B (sv) * 1988-09-02 1991-02-04 Amsu Ltd Komposition foer behandling av erektil dysfunktion via uretra
US4889238A (en) * 1989-04-03 1989-12-26 The Procter & Gamble Company Medicament package for increasing compliance with complex therapeutic regimens
US5059603A (en) * 1989-06-12 1991-10-22 Centuries Laboratories, Inc. Method and composition for treating impotence
US5242391A (en) * 1990-04-25 1993-09-07 Alza Corporation Urethral insert for treatment of erectile dysfunction
EP0526566B1 (en) * 1990-04-25 1998-11-25 Vivus, Inc. Treatment of erectile dysfunction
EP0459666B1 (en) * 1990-05-31 1994-11-09 Pfizer Inc. Medicaments against impotence
US5399581A (en) * 1990-12-26 1995-03-21 Laragh; John H. Method and compositions for treatment of sexual impotence
US5148920A (en) * 1991-03-18 1992-09-22 Zimmer, Inc. Package and package insert
DE4117249C2 (de) * 1991-05-27 1998-05-14 Christian Dr Stief Linsidomin zur Behandlung erektiler Dysfunktionen
AU2300092A (en) * 1991-07-03 1993-02-11 Nathan E. Scott Prostaglandin e2 treatment of impotence
US5482039A (en) * 1994-03-25 1996-01-09 Vivus, Inc. Process for diagnosing erectile dysfunction, and related methods of treatment

Also Published As

Publication number Publication date
NO974062D0 (no) 1997-09-04
PL322268A1 (en) 1998-01-19
NZ305560A (en) 1998-11-25
US5820587A (en) 1998-10-13
CA2215307A1 (en) 1996-09-19
ES2110380T1 (es) 1998-02-16
MX9707038A (es) 1997-11-29
EP0814775A1 (en) 1998-01-07
JPH10505611A (ja) 1998-06-02
DE814775T1 (de) 1998-06-25
CZ278497A3 (cs) 1998-04-15
HUP9801324A2 (hu) 1998-09-28
KR19980703052A (ko) 1998-09-05
HUP9801324A3 (en) 1999-03-29
AU5358896A (en) 1996-10-02
TR199700930T2 (xx) 1998-07-21
SK124397A3 (en) 1998-12-02
BR9607365A (pt) 1997-12-30
WO1996028142A1 (en) 1996-09-19

Similar Documents

Publication Publication Date Title
NO974062L (no) Fremgangsmåte og kitt for å hindre erektil funksjonssvikt
IS1956B (is) Meðferð MS sjúkdóms og annarra afmýlimeina með lofepramíni ásamt L-fenýlalaníni, týrósíni eða tryptófani og hugsanlega B12 vítamínsambandi
WO1997036609A3 (en) Combinations of vasopressin and adrenergic agents for the treatment of cardiac arrest
DE69318139D1 (de) Erleichterte sauerstoffabgabe im zusammenhang mit blutverdünnung
DK0913156T3 (da) Anvendelse af aktiveret protein C til behandling af hyperkoagulationstilstande i forbindelse med sepsis
DE69633195D1 (de) Injektierbare oder implantierbare biomaterialien zum füllen oder abdecken von hohlräumen und lumen eines körpers
NO963916L (no) Fremgangsmåte og apparat for diagnotisering av erektil funksjonssvikt
ES2176476T3 (es) Disolucion acuosa biocompatible para uso en dialisis peritoneal ambulatoria.
CA2265839A1 (en) Noded cuffs for transcutaneous or intrabody prosthetic devices
CA2294921A1 (en) Levobupivacaine and its use
NO20000087L (no) Behandling av inflammatoriske sykdommer i tarmen og urinblære
HUP9902094A2 (hu) PGE-1-tartalmú liofilizált liposzómák erekciós zavar kezelésében való alkalmazásra
DE69627160D1 (de) Pharmazeutische zusammensetzung enthaltend 3-(2,2,2-trimethylhydrazinium)proprionat und gamma-butyrobetain für die behandlung von herz-gefäss-erkrankungen
Casey Revascularization of corpus cavernosum for erectile failure
NO984572D0 (no) Anvendelse av 2,5-dihydroksybenzensulfonderivater for fremstilling av legemidler ment for normalisering av den endoteliale funksjon, for behandling av seksuell dysfunksjon og vaskulµre komplikasjoner i diabetes, sÕvel som vaskulµre lidelser av e
WO1995016435A3 (en) Improved intraocular irrigating solution containing non-steroidal antiinflammatory agent
PL341202A1 (en) Levosimedane preparations for administration through mucous membranes
CO5280202A1 (es) Metodos de tratamiento y metodos de rastreo de farmacos
SU1641290A1 (ru) Способ протезировани брюшной аорты и подвздошных артерий
MD1469G2 (ro) Metodă de tratament al şocului combustional
FI924088A0 (fi) Anvaendning av prostaglandin f3a som oegontryck saenkande medel.
UA10744A (uk) Спосіб лікуваhhя судиhhої імпотеhції
RU95103180A (ru) Способ обработки культи аппендикса при аппендэктомии
UA13917A (uk) Проточhо-аспіраційhий апарат для лікуваhhя раh та порожhиh в післяопераційhий період
UA22223A (uk) Спосіб лікуваhhя захворюваhь оргаhа зору